GlaxoSmithKline PLC (OTCQB:GLAXF)

28.15
Data as of 11:18am ET
 +0.16 / +0.57%
Today’s Change
24.12
Today|||52-Week Range
28.56
+6.43%
Year-to-Date
Update on Glaxo/Theravance's COPD Drugs - Analyst Blog
7:09pm / Zacks.com
US Stock Futures Edge Higher Ahead Of McDonald's Earnings
Apr 22 / Benzinga
Healthcare M&A activity hits record level
12:43pm / Fortune
Botox maker gets $46 billion bid
Apr 22 / CNNMoney.com
Botox at the Center of Recent Healthcare M&A Flurry
11:13am / TheStreet.com
Why GlaxoSmithKline (GSK) Stock Is Higher This Morning
Apr 22 / TheStreet.com
Epizyme Up on Milestone Payment from Glaxo - Analyst Blog
Apr 23 / Zacks.com
Market Hustle: Stock Futures in Wait-and-See Mode
Apr 22 / TheStreet.com
Novartis Signs Deals With GlaxoSmithKline & Eli Lilly - Analyst Blog
Apr 23 / Zacks.com
European Stocks Rise, Led by Pharma Sector News
Apr 22 / TheStreet.com
Novartis Signs Deals with Glaxo, Lilly - Analyst Blog
Apr 23 / Zacks.com
Stocks: Pharma, earnings in the spotlight
Apr 22 / CNNMoney.com
Stock Market News for April 23, 2014 - Market News
Apr 23 / Zacks.com
The Biggest Biotech Wins of the Week
Apr 21 / MotleyFool.com
Will This Analyst Upgrade Help GlaxoSmithKline (GSK) Today?
Apr 23 / TheStreet.com
Why Sarepta Therapeutics Inc. Shares Skyrocketed
Apr 21 / MotleyFool.com
Market Wrap: Health Care Mergers Aplenty; Conn's Pops on Greenlight Stake; GM (GM) Co...
Apr 22 / Investing Channel
Emerging 'Superbugs' -- and Why Investors Should Care
Apr 21 / TheStreet.com
Market Wrap: Health Care Mergers Aplenty; Conn's Pops n Greenlight Stake; GM (GM) Con...
Apr 22 / Investing Channel
The FDA Gives Sarepta Therapeutics Inc. a Way Forward: Now What?
Apr 21 / MotleyFool.com
Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq Also Positiv...
Apr 22 / Benzinga
4 Reasons You Should Watch This Under-the-Radar Stock on Your Watchlist
Apr 18 / MotleyFool.com
5 reasons to care about Ackman's Botox bet
Apr 22 / CNNMoney.com
In Case You Missed It: GlaxoSmithKline Just Had a Phenomenal Week!
Apr 18 / MotleyFool.com
Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)
Apr 22 / Benzinga
Glaxo Looking into Misconduct Charges - Analyst Blog
Apr 17 / Zacks.com
Is This a Good Deal for Novartis AG and GlaxoSmithKline plc?
Apr 22 / MotleyFool.com
Pharmaceutical Stocks For Income, Value, And Growth Investors
Apr 17 / Benzinga
Tuesday Links: Bullish On Hedge Funds
Apr 22 / StockTwits
Glaxo's Tanzeum Approved in the U.S. - Analyst Blog
Apr 16 / Zacks.com
Why Epizyme Inc. Shares Rocketed Higher
Apr 22 / MotleyFool.com
Is Johnson & Johnson's Dividend Unbeatable?
Apr 16 / MotleyFool.com
Novartis Reshapes Portfolio via GSK, Eli Lilly Deals
Apr 22 / TheStreet.com
Dynavax Starts Phase III Study on Heplisav-B - Analyst Blog
Apr 16 / Zacks.com
Notable Mergers and Acquisitions of the Day 04/22: (GSK)/(NVS) (VRX)/(AGN) (CDNS)
Apr 22 / Investing Channel
Mylan Inks Two Separate Agreements - Analyst Blog
Apr 16 / Zacks.com
5 Stories You Can't Miss About Big Pharma, Facebook: StockTwits
Apr 22 / TheStreet.com
Down 17%: Is Isis Pharmaceuticals Worth Buying Now?
Apr 15 / MotleyFool.com
Stocks Flirt With All-Time Highs on Earnings, Deals News
Apr 22 / TheStreet.com
Why Investors Need to Watch Sarepta Therapeutics Inc.
Apr 15 / MotleyFool.com
GlaxoSmithKline (GSK): Heavy Pre-Market Activity
Apr 22 / TheStreet.com
Tuesdaybs Top Health Care Stories: Johnson & Johnson, Teva, Mylan, and Dynavax
Apr 15 / MotleyFool.com
Sarepta's Roller Coaster Hits a High Point
Apr 22 / MotleyFool.com
The Supreme Court Will Decide the Fate of a Blockbuster
Apr 14 / MotleyFool.com
Day Ahead: Awash in Earnings
Apr 22 / TheStreet.com
Impax Breathes New Life Into Stalled Parkinson's Drug
Apr 14 / MotleyFool.com
Today's Health Care Stocks to Watch: Eli Lilly and Co, GlaxoSmithKline plc, Novartis ...
Apr 22 / MotleyFool.com
Alli weight-loss drug recalled for tampering
Mar 27 / CNNMoney.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.